El tratamiento amodiaquina-sulfadoxinapirimetamina tiene eficacia del 98 por ciento para la malaria falciparum no complicada (Antioquia, Colombia; 2003)

Carmona Fonseca, Jaime; Tobón C., Alberto; Álvarez S., Gonzalo; Blair Trujillo, Silvia.
Iatreia ; 18(1): 5-26, mar. 2005. tab, graf
Artículo en Español | LILACS | ID: lil-406180

Documentos relacionados

  1. Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation.
  2. Gametocitemia en malaria falciparum tratada con amodiaquina o artesunato
  3. Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.
  4. Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540.
  5. Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
  6. Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990-2020.
  7. Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.
  8. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
  9. Mutaciones puntuales en los genes dhfr y dhps de Plasmodium falciparum de tres regiones endémicas para malaria en Colombia
  10. High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?